Budget Express 2026

co-presented by

  • JIO BlackRock

ASSOCIATE SPONSORS

  • Sunteck
  • SBI
HomeNewsJm financial institutional securities

Jm Financial Institutional Securities

Jump to
  • JM Financial former VP, other settle insider trading case with Sebi, pays Rs 1.24 cr

    The regulator had initiated proceedings and sent notices to Saraogi and Vimala in 2017 wherein it was alleged that both violated PIT (Prohibition of Insider Trading) norms.

  • Cochin Shipyard files papers for Rs 1,400-1,500 crore IPO

    State-owned Cochin Shipyard today filed draft papers with capital markets regulator Sebi to raise an estimated Rs 1,400-1,500 crore through an initial public offering.

  • We will soon be entering a buy zone: JM Financial

    Speaking to CNBC-TV18 Suhas Harinarayanan, JM Financial Institutional Securities, says markets were expensive a couple of months ago.

  • NSE ropes in Citigroup, Morgan Stanley to handle IPO

    The other joint global co-ordinators are JM Financial Institutional Securities and Kotak Mahindra Capital Company. Besides, the exchange has engaged Cyril Amarchand Mangaldas as the legal advisor.

  • See earnings growth in double-digits in FY17: JM Financial

    India's growth is largely being driven by global factors at the moment and some domestic factors are also pricing in, says Suhas Harinarayanan of JM Financial Institutional Securities.

  • Parag Milk to make stock market debut on Thursday

    The company's Rs 760-crore initial public offering (IPO), which was extended by three days, was oversubscribed 1.83 times on the final day of the offer which ended on May 11.

  • Thyrocare's Rs 479 cr IPO oversubscribed 2.24 times on Day 2

    The initial public offering (IPO) of diagnostics company Thyrocare Technologies has been over subscribed 2.24 times on the second day of the offer today.

  • Thyrocare IPO fully subscribed

    The Rs 479.21-crore IPO received bids for 77,30,514 shares against the total issue size of 75,21,297 shares, as per the NSE data till 1200 hrs.

  • Thyrocare to raise nearly Rs 480 crore through IPO

    The firm, which runs a diagnostics laboratory chain across the country, will come out with a public issue of up to 10,744,708 equity shares of Rs 10 each for cash.

  • Thyrocare, Ujjivan IPOs to hit markets next week

    The bidding for shares in the IPO of Ujjivan Financial will remain open from April 28-May 2, 2016, according to a public announcement.

  • Thyrocare Technologies receives Sebi's approval for IPO

    The company, which had filed its draft red herring prospectus (DRHP) with Sebi on December 31 for launching the IPO, received clearance from the regulator on February 24, according to the latest update.

  • JM Financial up 7% on pact for investment banking services

    JM Financial and Seabury will jointly provide investment banking advisory services to each party's clients who may be seeking investment opportunities or may like to identify suitable strategic partnerships for their respective businesses.

  • Sebi clears Nuziveedu Seeds' IPO; total number reaches 24

    The Securities and Exchange Board of India (Sebi) issued its final observations on the draft offer document of the company on August 5, which is necessary for any company to launch a public offer.

  • Expect no further earnings cut in FY16: JM Financial

    Calling MSP rate hike to be ‘modest‘, Suhas Harinarayanan, Executive Director- Institutional Equity Research, JM Financial Institutional Securities said this is one of the few steps taken to ensure that food inflation is under control.

  • Here's what JM Fin recommends buying in pharma space now

    Among large caps, Anmol Ganjoo likes Dr. Reddy‘s Labs, Lupin and Cipla. He picks Ipca and Torrent Pharma from the mid cap space.

  • Hotel Leela up 12% on debt reduction plan, to sell 2 hotels

    As part of the restructuring programme, the company has embarked on an asset light strategy to pare down its debt and has appointed JM Investment Banking as its financial advisor. As part of this process, expressions of interest are being invited for The Leela Goa and The Leela Palace Chennai.

  • ONGC to remain between Rs 250-270: Mehul Thanawala

    Mehul Thanawala of JM Financial Institutional Securities expects Oil and Natural Gas Corporation (ONGC) to remain in Rs 250-270 range in the near term.

  • Under-recoveries a worry; buy RIL with 2-3 yr view: JM Fin

    Mehul Thanawala of JM Financial Institutional Securities talks about upstream companies such as ONGC and GAIL, their under-recovery position and stock price. He talks about whether there is a possibility of a re-rating of the GAIL stock. He also shares his views on Oil India and Cairn.

  • See 25bps cut in Jan; positive on JLR, pvt banks: JM Fin

    Sameer Lumba of JM Financial Institutional Securities believes the JLR franchise remains strong and therefore, they are positive about the stock and approaching it with a long-term view. "JLR obviously has a very strong franchise. I don‘t see longer term challenges there for the franchise that they have built," he explained.

  • Bullish on rural and consumer finance NBFCs: JM Financial

    Non-Banking Financial Companies (NBFCs) reported a pretty strong set of numbers during the current quarter, says Karan Uberoi of JM Financial Institutional Securities. "Most of the retail based NBFCs reported earnings growth of about 25-30 percent with healthy loan growth in excess of 20 percent," he adds.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347